Literature DB >> 23411032

Contribution of the inflammasomes to autoinflammatory diseases and recent mouse models as research tools.

Michael C Heymann1, Angela Rösen-Wolff.   

Abstract

Inflammasomes are multiprotein complexes that serve as activating platforms for the enzyme caspase-1 in response to various danger signals. Active caspase-1 can cleave the precursors of the pro-inflammatory cytokines IL-1β and IL-18 and thereby activate them. Deregulation of this cascade caused by mutations in genes coding for inflammasomal components and their interaction partners can lead to severe disease. This review summarizes the contribution of deregulated inflammasomes to the field of autoinflammatory syndromes. In addition, it gives insight into currently available mouse models that are used to study and characterize the role of the inflammasome components in the pathophysiology of these diseases.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23411032     DOI: 10.1016/j.clim.2013.01.006

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  5 in total

Review 1.  Cathepsin B: multiple roles in cancer.

Authors:  Neha Aggarwal; Bonnie F Sloane
Journal:  Proteomics Clin Appl       Date:  2014-03-26       Impact factor: 3.494

Review 2.  A Comprehensive Review of Neutrophilic Diseases.

Authors:  Angelo V Marzano; Alessandro Borghi; Daniel Wallach; Massimo Cugno
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 3.  Neutrophils in animal models of autoimmune disease.

Authors:  Tamás Németh; Attila Mócsai; Clifford A Lowell
Journal:  Semin Immunol       Date:  2016-04-07       Impact factor: 11.130

4.  Identification and validation of uterine stimulant methylergometrine as a potential inhibitor of caspase-1 activation.

Authors:  Guillermo García-Laínez; Mónica Sancho; Vanessa García-Bayarri; Mar Orzáez
Journal:  Apoptosis       Date:  2017-10       Impact factor: 4.677

5.  Identification of an ASC oligomerization inhibitor for the treatment of inflammatory diseases.

Authors:  Paula M Soriano-Teruel; Guillermo García-Laínez; María Marco-Salvador; Julián Pardo; Maykel Arias; Christian DeFord; Irmgard Merfort; María J Vicent; Pablo Pelegrín; Mónica Sancho; Mar Orzáez
Journal:  Cell Death Dis       Date:  2021-12-13       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.